Clinical Trials Directory

Trials / Conditions / Facioscapulohumeral Muscular Dystrophy 1

Facioscapulohumeral Muscular Dystrophy 1

9 registered clinical trials studyying Facioscapulohumeral Muscular Dystrophy 1 — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
NCT07038200
Avidity Biosciences, Inc.Phase 3
RecruitingBetterLife FSHD: A Patient-driven Health and Research Platform
NCT07409142
FSHD Society—
Enrolling By InvitationPhase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FS
NCT06547216
Avidity Biosciences, Inc.Phase 2
Active Not RecruitingStudy to Evaluate the Efficacy and Safety of Satralizumab in FSHD1
NCT06222827
Centre Hospitalier Universitaire de NicePhase 2
CompletedUltrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity Findings
NCT07331025
Koç University—
Active Not RecruitingPhase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT05747924
Avidity Biosciences, Inc.Phase 1 / Phase 2
CompletedMusculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders
NCT04907162
LMU Klinikum—
UnknownValidation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal
NCT05295277
Bionano Genomics—
TerminatedEvaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod fo
NCT04004000
Fulcrum TherapeuticsPhase 2